Plaza Ballrooms / University of Wisconsin FDA Presentations Background / Rockville Pike / University of Nevada Benefit Risk Assessment / University of Wisconsin School / /
IndustryTerm
age groups / drug product / age / subpopulation / combination products / /
MedicalCondition
Pulmonary / asthma / disease / /
OperatingSystem
OSE / /
Organization
FDA office of Surveillance and Epidemiology Summary Remarks / office of Biostatistics / Pulmonary and Allergy Products Office / Pediatric Advisory Committee / Drug Safety and Risk Management Committee / office of Pediatric Therapeutics / Stanford University School of Medicine / Nancy Sander / Allergy and Asthma Network Mothers of Asthmatics / American Academy of Allergy / Asthma / and Immunology / University of Nevada / New Drugs Office / FDA office of Surveillance / American Thoracic Society / Drug Safety and Risk Management Advisory Committee / National Medical Association / Pulmonary-Allergy Drugs Advisory Committee / U.S. Food and Drug Administration / Joint Pulmonary-Allergy Drugs Advisory Committee / FDA Division of Pulmonary / office of Surveillance & Epidemiology Joint / Advisory Committee / Center for Drug Evaluation / University of Wisconsin School of Medicine / University of Wisconsin / /
Person
Catherine Bonuccelli / Julian Dorsey / Sean Hennessy / Brahm Goldstein / Kevin Carroll / Nancy Sander / Mark Brantly / Opening Remarks Ann McMahon / Amy Celento / Avital Cnaan / Shelley Salpeter / Elaine Vining Pediatric / Badrul Chowdhury / Tomas Andersson / Foradil Linda Armstrong / Edward Krenzelock / John Hoidal / Judith Kramer / Daniel Notterman / Agonists Sally Seymour / David Schoenfeld / David Margolis / Anne Dorsey / Sebastian Schneeweiss / Alfred Munzer / Stuart Stoloff / Sally Seymour / Julie Zito / Robert Lemanske / Kristine Khuc / Sydney Wolfe / Lee Newman / Ann McMahon / Fernando Martinez / D. Bruce Burlington / Mark Levenson / Foradil Mathias Hukkelhoven / John Jenkins / Daren L. Knoell / Andrea Holka / Respiratory Medicines / David Graham / M. Dianne Murphy / Andrew Mosholder / Henry Francis / Robert Nelson / Carolyn Britton / Geoffrey Rosenthal / Curtis Rosebraugh / C. Elaine Jones / Melissa Hudson / Katherine Knobil / Stanley Szefler / Erik Swenson / Jesse Joad / Keith Kocis / Remarks Badrul Chowdhury / Marsha Rappley / Deborah Shatin / Jacqueline Gardner / /
Position
Director for Science and Medicine / Director / Division / Director / Clinical Development and Medical Affairs / Professor of Family and Community Medicine / Vice President / Speaker / Designated Federal Official / Deputy Director / Office / Medical Officer / Division of Epidemiology / Chair Acting Committee / Vice President / Statistics and Chief Statistician / Federal Official / Professor of Pediatric Medicine / Medical Science Director / Acting Director / Division of Pharmacovigilance / Global Head of Drug Regulatory Affairs / Director / Associate Director / Vice President / Respiratory Regulatory Affairs / Commissioner / Director / Division of Pulmonary and Allergy Products / Co-Chair / Vice President / Development Projects / Symbicort / Representative / Senior Vice President / Global Head / Deputy Director for Safety / Division / Executive Medical Director / Clinical Development and Medical Affairs / Director / Division of Pulmonary Allergy Products / Director / Division of Pharmacovigilance / Acting Chair / Chair / /
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived